A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2011
03/17/2011	US20110065770 Formulations comprising antisense nucleotides to connexins
03/17/2011	US20110065761 Methods of treating nerve-related vision disorders
03/17/2011	US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/17/2011	US20110065661 Pharmacoperones for correcting disease states involving protein misfolding
03/17/2011	US20110065654 Compositions and methods for alzheimer's disease
03/17/2011	US20110065653 Tat-utrophin as a protein therapy for dystrophinopathies
03/17/2011	US20110065652 Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction
03/17/2011	US20110065651 Heterocyclic substituted piperazines with cxcr3 antagonist activity
03/17/2011	US20110065650 Methods of Inhibiting Tumor Cell Proliferation
03/17/2011	US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
03/17/2011	US20110065648 Advantageous mu-opiate receptor peptide compounds
03/17/2011	US20110065647 Novel peptides isolated from spider venom, and uses thereof
03/17/2011	US20110065646 Use of a Homeoprotein of the Bicoid Family for Preventing or Treating Retinal Ganglionic Neuron Degeneration
03/17/2011	US20110065645 Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance
03/17/2011	US20110065644 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
03/17/2011	US20110065643 Clusterin Pharmaceuticals and Treatment Methods Using the Same
03/17/2011	US20110065642 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065640 Anti-invasive and anti-angiogenic compositions
03/17/2011	US20110065639 Compositions and methods for visualizing and eliminating cancer stem cells
03/17/2011	US20110065638 Novel crustacean androgenic gland hormone
03/17/2011	US20110065637 Method to reduce SLOSH energy absorption and its damaging effects through the reduction of inelastic collisions in an organism
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065635 Methods and compositions for modulating insulin regulation
03/17/2011	US20110065634 Glucagon receptor antagonists, compositions, and methods for their use
03/17/2011	US20110065633 Ester-based peptide prodrugs
03/17/2011	US20110065632 Pharmaceutical compositions of somatostatin-dopamine conjugates
03/17/2011	US20110065631 Process for preparation of hiv protease inhibitors
03/17/2011	US20110065630 Use of a octreotide as a therapeutic agent
03/17/2011	US20110065629 Enteral nutrient
03/17/2011	US20110065628 Medication Combinations for the Treatment of Alcoholism and Drug Addiction
03/17/2011	US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes
03/17/2011	US20110065178 Dendritic cell potentiation
03/17/2011	US20110065177 Novel Collectin
03/17/2011	US20110065174 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
03/17/2011	US20110065147 Methods and reagents for modulating cholesterol levels
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
03/17/2011	US20110064828 Treatment of metastatic tumors and other conditions
03/17/2011	US20110064821 Encapsulation of biologically active agents
03/17/2011	US20110064818 Pharmaceutical composition and a method for the production thereof
03/17/2011	US20110064800 Nanoparticulate and controlled release compositions comprising cyclosporine
03/17/2011	US20110064799 Pancreatic Enzyme Compositions and Methods for Treating Pancreatitis and Pancreatic Insufficiency
03/17/2011	US20110064795 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
03/17/2011	US20110064793 Inhibitors of hiv replication and method of treatment of hiv infections
03/17/2011	US20110064792 Method for Opening Tight Junctions
03/17/2011	US20110064791 Self forming, thermodynamically stable liposomes and their applications
03/17/2011	US20110064784 Method for producing a three-dimensional macroporous filament construct based on phase inversion and construct thereby obtained
03/17/2011	US20110064782 Methods and compositions for tissue regeneration
03/17/2011	US20110064762 Protein a compositions and methods of use
03/17/2011	US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064748 Pharmaceutical combination and method for treating tumor
03/17/2011	US20110064747 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
03/17/2011	US20110064742 Somatostatin Receptor Antagonists and Glucose Control or Hypoglycemia
03/17/2011	US20110064741 Stable amyloid beta monomers and oligomers
03/17/2011	US20110064739 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung
03/17/2011	US20110064735 Methods for treating lymphomas in certain patient populations and screening patients for said therapy
03/17/2011	US20110064734 Prevention and treatment of amyloidogenic disease
03/17/2011	US20110064729 Administration of agents for the treatment of inflammation
03/17/2011	US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof
03/17/2011	US20110064722 Modulators of alpha-synuclein toxicity
03/17/2011	US20110064721 Cathepsin-d neuroprotection
03/17/2011	US20110064720 Dietary Supplement Compositions and Methods of Making and Using the Same
03/17/2011	US20110064719 Hydrophobic interaction chromatography purification of factor vii polypeptides
03/17/2011	US20110064718 Pesticidal and Antiparasitic Compositions
03/17/2011	US20110064717 Homing endonuclease genes and their targets
03/17/2011	US20110064716 Materials and methods for treating or preventing organophosphate exposure associated damage
03/17/2011	US20110064715 Methods for determining oligosaccharide binding
03/17/2011	US20110064714 Factor viia-polysialic acid conjugate having prolonged in vivo half-life
03/17/2011	US20110064713 Methods of Treating Cancer Using Opioid Retargeted Endopepidases
03/17/2011	US20110064712 Dietary Supplement Compositions and Methods of Making and Using the Same
03/17/2011	US20110064711 Compositions containing coenzyme q-10 and an antioxidant
03/17/2011	US20110064708 Methods And Compositions For The Dietary Management Of Autoimmune Disorders
03/17/2011	US20110064698 Hepatitis c virus inhibitors
03/17/2011	US20110064697 Hepatitis c virus inhibitors
03/17/2011	US20110064696 Hepatitis c virus inhibitors
03/17/2011	US20110064695 Hepatitis c virus inhibitors
03/17/2011	US20110064694 Anti-hepatitis c activity of meso-tetrakis-porphyrin analogues
03/17/2011	US20110064693 Antiviral Drugs for Treatment of Arenavirus Infection
03/17/2011	US20110064692 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression
03/17/2011	US20110064691 Method to enhance hematopoiesis
03/17/2011	US20110064690 Pegylated Interleukin-10
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064671 Modulation of blood brain barrier permeability
03/17/2011	US20110064669 Use of galanin in a method of treating neurodegenerative diseases or conditions
03/17/2011	US20110064668 J-superfamily conotoxin peptides
03/17/2011	US20110064664 Methods and compositions involving chitosan nanoparticles
03/17/2011	US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use
03/17/2011	US20110064658 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
03/17/2011	US20110064654 Prostate cancer diagnosis and treatment
03/17/2011	US20110062046 Tissue adhesives and sealants and methods for their use
03/17/2011	DE102005041616B4 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and coding for these polynucleotides and uses thereof
03/17/2011	CA2774140A1 Vaccines directed to langerhans cells
03/17/2011	CA2773664A1 Composition for treatment of cxcl8-mediated lung inflammation
03/17/2011	CA2773490A1 A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
03/17/2011	CA2773192A1 Plgf-1 in homodimeric form

1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 3163